Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Short-term 12-Week, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study to Evaluate the Treatment Effect of Saxagliptin Compared With Placebo in Adult Patients With Type 2 Diabetes and Renal Impairment (Moderate, Severe, and End-Stage) With an Additional 40-week, Randomized, Double-blind, Placebo-controlled Long-term Observational Period.
Brief Summary: Saxagliptin is a new investigational medication being developed for treatment of type 2 diabetes. This study is designed to test the efficacy of once daily saxagliptin in renally impaired patients.


Options:
A: Arm Label: Insulin degludec (IDeg); Type: EXPERIMENTAL; Interventions: Drug: insulin degludec | Arm Label: Insulin glargine (IGlar); Type: ACTIVE_COMPARATOR; Interventions: Drug: insulin glargine | Intervention Type: DRUG; Name: insulin degludec; Assigned to Arm(s): Insulin degludec (IDeg) | Intervention Type: DRUG; Name: insulin glargine; Assigned to Arm(s): Insulin glargine (IGlar)
B: Arm Label: Saxagliptin 2.5 mg + Glyburide 7.5 mg (A); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin, Drug: Glyburide, Drug: Metformin | Arm Label: Saxagliptin 5 mg + Glyburide 7.5 mg (B); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin, Drug: Glyburide, Drug: Metformin | Arm Label: Placebo + Glyburide 7.5 mg (C); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Glyburide, Drug: Metformin | Intervention Type: DRUG; Name: Saxagliptin; Assigned to Arm(s): Saxagliptin 2.5 mg + Glyburide 7.5 mg (A) | Intervention Type: DRUG; Name: Saxagliptin; Assigned to Arm(s): Saxagliptin 5 mg + Glyburide 7.5 mg (B) | Intervention Type: DRUG; Name: Glyburide; Assigned to Arm(s): Saxagliptin 2.5 mg + Glyburide 7.5 mg (A), Saxagliptin 5 mg + Glyburide 7.5 mg (B) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + Glyburide 7.5 mg (C) | Intervention Type: DRUG; Name: Glyburide; Assigned to Arm(s): Placebo + Glyburide 7.5 mg (C) | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Placebo + Glyburide 7.5 mg (C), Saxagliptin 2.5 mg + Glyburide 7.5 mg (A), Saxagliptin 5 mg + Glyburide 7.5 mg (B)
C: Arm Label: Saxa; Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin | Arm Label: Placebo; Type: NO_INTERVENTION; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Saxagliptin; Assigned to Arm(s): Saxa | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Intensive glycemia control; Type: EXPERIMENTAL; Interventions: Drug: Hypoglycemic Agents | Arm Label: Standard glycemia control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard glycemia control | Arm Label: Intensive BP control; Type: EXPERIMENTAL; Interventions: Drug: Intensive BP treatment | Arm Label: Standard BP control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard BP control | Arm Label: Fibrate; Type: EXPERIMENTAL; Interventions: Drug: Fenofibrate, Drug: Simvastatin | Arm Label: Fibrate Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Simvastatin, Drug: Placebo | Intervention Type: DRUG; Name: Hypoglycemic Agents; Assigned to Arm(s): Intensive glycemia control | Intervention Type: DRUG; Name: Standard glycemia control; Assigned to Arm(s): Standard glycemia control | Intervention Type: DRUG; Name: Intensive BP treatment; Assigned to Arm(s): Intensive BP control | Intervention Type: DRUG; Name: Standard BP control; Assigned to Arm(s): Standard BP control | Intervention Type: DRUG; Name: Fenofibrate; Assigned to Arm(s): Fibrate | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): Fibrate, Fibrate Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Fibrate Placebo

Answer: C